title: Editorial: IDASPHERE phase I trial for chemoembolisation for HCC - authors' reply: a necessary step for treatment optimisation and standardisation.
authors.affiliation: INSERM U866, University of Burgundy, Dijon, France; Department of Pharmacy, University Hospital, Dijon, France. mathieu.boulin@chu-dijon.fr.
authors.forename: M
authors.initials: M
authors.lastname: Boulin
authors.forename: L
authors.initials: L
authors.lastname: Bedenne
authors.forename: B
authors.initials: B
authors.lastname: Guiu
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male
chemical_list: D015255:Idarubicin